Spoonbill Pushes FDA for 4'-PPT in Special Medical Diets
Published Date: 7/29/2025
Proposed Rule
Summary
The Spoonbill Foundation asked the FDA to approve a new nutrient called 4'-phosphopantetheine (4'-PPT) for use in medical foods. If approved, this change will help people who rely on special medical diets get safer, better nutrition. The FDA is now reviewing the petition, and any updates could affect medical food makers and patients soon.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
FDA Reviewing 4'-PPT for Medical Foods
The FDA has filed a petition to allow 4'-phosphopantetheine (4'-PPT) to be used as a nutrient in medical foods. If approved, this could help people who rely on special medical diets get safer, better nutrition.
Potential Impact on Medical Food Makers
The petition proposes amending food additive rules to permit 4'-PPT in medical foods, which could change what medical food makers are allowed to use. The FDA review and any future regulatory update could affect medical food manufacturers.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2025-14335, APIX Biosciences US LLC; Filing of Food Additive Petition (Animal Use)
APIX Biosciences wants the FDA to approve using cholesterol safely in honeybee food. This change could help beekeepers feed their bees better, keeping them healthy. If approved, it might start soon and won’t cost extra for most folks, but it’s a big win for buzzing buddies everywhere!
Next: 2025-14342, Takes of Marine Mammals Incidental to Specified Activities; Taking Marine Mammals Incidental to Alaska LNG Project in Cook Inlet
The Alaska LNG Project in Cook Inlet wants permission to accidentally affect some marine mammals while working from 2026 to 2030. NMFS is proposing rules to protect these animals as much as possible and wants your thoughts before making a final decision. This plan balances energy progress with caring for wildlife, and it could impact how the project operates and reports its activities.